La Jolla, CA, United States of America

Qiang Li

This inventor holds 1 USPTO granted patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qiang Li. Retrieved from https://idiyas.com/inventor/qiang-li-3c06fx9f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Qiang Li in Pharmaceutical Research

Introduction

Qiang Li is a notable inventor based in La Jolla, California. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on 15-PGDH inhibitors. His research focuses on developing compounds that have the potential to impact various medical applications.

Latest Patents

Qiang Li holds one patent related to 15-PGDH inhibitors. This patent describes a compound characterized by specific formulas, including formula (1), formula (2), formula (3), and formula (4), or a pharmacologically acceptable salt thereof. This invention showcases his commitment to advancing pharmaceutical science.

Career Highlights

Qiang Li is associated with Kyorin Pharmaceutical Co., Ltd., where he applies his expertise in drug development. His work at this esteemed company highlights his dedication to improving healthcare through innovative solutions.

Collaborations

Qiang Li collaborates with talented colleagues, including Shyama Herath and Mariangela Urbano. These partnerships enhance the research environment and contribute to the success of their projects.

Conclusion

Qiang Li's contributions to pharmaceutical research, particularly through his patent on 15-PGDH inhibitors, demonstrate his innovative spirit and commitment to advancing medical science. His work continues to inspire future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…